Welcome to YLOAN.COM
yloan.com » Medical » Pfizer Inc looses battle for German generic-drug maker
Health Medical Acne Aerobics-Cardio Alternative Anti-Aging Build-Muscle Chronic-Illness Dental-Care Depression Diabetes Disability Exercise Eye-Care Fitness-Equipment Hair-Loss Medicine Meditation Nutrition Obesity Polution Quit-Smoking Sidha Supplements Yeast Infection H1N1 Swine Flu SARS herpes therapy panic surgeon hurts teeth remedies eliminate chiropractic arthritis ingredients syndrome binding anxiety surgery medication psychic dental reflux doctor relief premature emotional stress disorder implants wrinkles vision infection aging liposuction seattle stunning sweating hair treatment tinnitus

Pfizer Inc looses battle for German generic-drug maker

Generic drug manufacturers are taking over brand name drugs faster than you can imagine.And

actually it is great for people because they are able to buy cheap and quality equivalents of brand name drugs.On the other hand huge brand name manufacturers are suffering from this situation.

So to improve their market, Pfizer Inc was set to present a nearly $4 billion offer for German generic-drug maker Ratiopharm GmbH, competing against rival bids from Teva Pharmaceutical Industries Ltd and Actavis.

Pfizer was expected to "be competitive" with a rival offer from Iceland's Actavis.

But on March 18 Teva Pharmaceutical Industries Ltd. agreed to buy Ratiopharm GmbH for 3.63 billion euros ($5 billion), ending a nine-month battle for Germany's second- biggest maker of generic medicines.


The acquisition is Teva's biggest since buyingBarr Pharmaceuticals Inc. for $7.4 billion in 2008. Ratiopharm gives the Israeli drugmaker a top spot in the $8.6 billion German market for copied drugs, the world's second-largest after the U.S.

The takeover catapults Teva into the top three generic-drug makers in Germany, alongside Novartis AG's Hexal unit andStada Arzneimittel AG. The deal also gives it 3 of the top 10 generic products by volume in the German retail drug market and 5 of the top 10 generic drugs sold to hospitals, according to data from IMS Health.Teva last year bought stakes in OncoGenex Pharmaceuticals Inc., gaining rights to an experimental cancer therapy, and Taisho Pharmaceutical Industries Ltd., increasing its access to the Japanese generic-drug market.

Visit Generic health blog for interesting news, uptades of Generic Industry.

Related articles:

How Generics are made?

Pfizer Inc looses battle for German generic-drug maker

By: JustinL
Medical coding & billing: Know the ICD-9 2011 changes Get Your Freedom With Medical Alarm Systems What A Doctor Needs To Do When Accused Of Medical Malpractice Stem Cells Have The Potential To Cure A Number Of Medical Disorders Signs of a functional Glendale Heights Walk-in Medical Clinic Medical Finance Made Easy Where To Get Medical Finance Best Acid Reflux Help - Forget Those Drugs and Discover How to Cure Your Problem Permanently Where Can You Find Medical Transcription Training With A Stipend? The Ups And Downs Of Starting A Medical Practice Biomarkers At The Cutting Edge Of Medical Research How Biomarkers Are Helping To Push Forward The Boundaries Of Medical Research Treating Patients With Alternative Medicine Techniques
print
www.yloan.com guest:  register | login | search IP(216.73.216.181) California / Anaheim Processed in 0.024228 second(s), 5 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 20 , 2369, 92,
Pfizer Inc looses battle for German generic-drug maker Anaheim